1Vion Dury J, Meyerhoff DJ, Cozzone PJ, et al. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? . J Neurol , 1994, 241(6) :354-371.
2Tedeschi G, Litvan I, Bonavita S, et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy,Parklnson' s disease and corticobasal degeneration. Brain,1997, 120(Pt 9) : 1541-1552.
3Lucetti C, Del Dotto P, Gambaccini G, et al. Proton magnetic resonance spectroscopy ( 1H - MRS) of motor cortex and basal ganglia in de novo Parkinson' s disease patients. Neurol Sci ,2001,22(1) : 68-70.
4Taylor- Robinson SD, Turjanski N, Bhattacharya S, et al. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson' s disease. Metab Brain Dis,1999, 14(1) : 45-55.
5Clarke CE, Lowry M, Horsman A. Unchanged basal ganglia N - acetylaspartate and glutamate in idiopathic Parkinson' s disease measured by proton magnetic resonance spectroscopy.Mov Disord, 1997, 12(3) :297-301.
6Hu MT, Taylor - Robinson SD, Chaudhuri KR, et al. Evidence for cortical dysfunction in clinically non - demented patients with Parkinson' s disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry, 1999, 67( 1 ) : 20-26.
7Federico F, Simone IL, Lucivero V, et al. Proton magnetic resonance spectroscopy in Parkinson' s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 1997, 62(3): 239-242.
8Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson' s disease using proton magnetic resonance spectroscopy. Ann Neurol,1995.37(2) :204-210.
9Penn AM, Roberts T, Hodder J, et al. Generalized mitochondrial dysfunction in Parkinson' s disease detected by magnetic resonance spectroscopy of muscle. Neurology, 1995, 45( 11 ) : 2097-2099.
10Hoang TQ, Bluml S, Dubowitz DJ, et al. Quantitative proton - deeoupled 31P MRS and 1H MRS in the evaluation of Huntington' s and Parkinson' s diseases. Neurology, 1998, 50(4): 1033-1044.
6Yamanouchi H,Nagural H.Neurolosical signs and frontal white matter lession in vescular parkinsonismcin[J].stroke,1997,28:965.
7Hely MA,Morris JG, Reid WG, et al. Sydney muhicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years[ J]. Mov Disord ,2005,20(2) : 190-199.
8Ponsen MM, Stoffers D, Booij J,et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease[J]. Ann Neurol,2004,56(2) : 173-181.
9Braak H, Ghebremedhin E, Rub U, et al. Stages in the development of Parkinson's disease-related pathology [ J]. Cell Tissue Res, 2004,318 ( 1 ) : 121-134.
